LYTIR

Company · BMY

Bristol-Myers Squibb Company

Name as listed on its exchange; filed with the SEC as BRISTOL MYERS SQUIBB CO.

Nasdaq's symbol directory lists BMY on the New York Stock Exchange as “Bristol-Myers Squibb Company Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 3 occasions ($678K); 3 planned-sale notices; 1 filing by holders of 5% or more; 4 congressional trade disclosures; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $678K in total.Aug: Insider sales $34KSep: Insider sales $403KNov: Insider sales $241KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $678K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Massacesi Cristian, EVP,Chief Med Offr,Head of Dev sold on 1 day latest Sep 9, 2026 sold $403K
  2. Haller Julia A sold on 1 day latest Nov 5, 2026 sold $241K
  3. Holzer Phil M, SVP and Controller sold on 1 day latest Aug 25, 2026 sold $34K
Every trade (3)
  1. SELLHaller Julia A sold Nov 5, 2026 3,800 shares filing $241K
  2. SELLMassacesi Cristian, EVP,Chief Med Offr,Head of Dev sold Sep 9, 2026 6,249 shares filing $403K
  3. SELLHolzer Phil M, SVP and Controller sold Aug 25, 2026 500 shares filing $34K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Julia A Haller Gottsch filed Nov 6, 2026 Director 3,800 shares planned sale date 11/05/2026 filing $250K
  2. Massacesi Cristian filed Sep 9, 2026 Officer 6,249 shares planned sale date 09/09/2026 filing $403K
  3. Holzer Phil M filed Aug 25, 2026 Officer 500 shares planned sale date 08/25/2026 filing $34K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. STATE STREET CORPORATION filed Aug 7, 2026 Schedule 13G passive 102,521,748 shares filing 5%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Mike Kelly (R-PA16): Sale May 7, 2026 reported Jun 11, 2026 one of 3 trades the member reported that day House Stocks (including ADRs) owner: spouse $15,001 - $50,000
  2. Alan Armstrong (R-OK): Purchase Mar 27, 2026 reported Jul 21, 2026 one of 703 trades the member reported that day Senate Stock $1,001 - $15,000
  3. Gilbert Cisneros (D-CA31): Purchase Dec 19, 2025 reported Jan 12, 2026 one of 121 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  4. Julie Johnson (D-TX32): Sale Dec 18, 2025 reported Jan 15, 2026 one of 62 trades the member reported that day House Stocks (including ADRs) owner: joint $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition; Regulation FD disclosure filing Oct 29, 2026
  2. Results of operations and financial condition; Regulation FD disclosure filing Jul 30, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.